Rosemarie de Haan

I have been working at the radiation oncology department at the Netherlands Cancer Institute since 2011. As part of my radiation oncology residency, I treat and guide cancer patients. I am also involved in research into combination treatment using PARP inhibitor olaparib (targeted therapy) and radiotherapy. The intensive and easily accessible collaborations, close commitment, and extensive experience of the team members throughout the entire organization make the Netherlands Cancer Institute a great place to work. Together we ensure that every patient receives treatment that is right for them.